“It’s been said that developing a drug is not rocket science, it’s actually much, much harder,” said Dan Skovronsky, MD, PhD and Chief Scientific Officer for Eli Lilly and Company. In this month’s podcast, you will hear how medicines are discovered and made.
Precision Health News
Specially trained field interviewers are going door-to-door statewide to collect information from Indiana residents about the environmental, social, genetic and behavioral factors that affect their lives and health.
Indiana University's Grand Challenges Program, including the IU Precision Health Initiative, was recently highlighted in the Indianapolis Business Journal's 2018 Innovation Issue.
Indiana University’s Precision Health Initiative has the resources and patient base to tackle common cancers, and the initiative wants more researchers to join the fight.
Indiana University’s Precision Health Initiative has ambitious plans for breakthrough cancer treatments using genomics and big data, and it seeks leaders to help win the fight.
Michael A. Weiss, MD, PhD, MBA, has been chosen to fill the dual role of leader of chemical biology and biotherapeutics for the Indiana University Precision Health Initiative and chair of the IU School of Medicine Department of Biochemistry and Molecular Biology.
Indiana University Precision Health Initiative leader Anantha Shekhar, MD, PhD, was interviewed by WNDU 16 journalist Maureen McFadden about how IU scientists and physicians are using precision medicine to successfully treat patients with cancer.
Kun Huang, PhD, an internationally recognized scientific and academic leader in bioinformatics and computing, has been named the director of data sciences and informatics for Indiana University’s first Grand Challenge initiative, Precision Health.
One of the largest gifts ever to the Indiana University School of Medicine will enable researchers to harness the power of the immune system to cure cancer and other devastating diseases -- propelling Indiana’s standing as an engine for biomedical discovery and innovation.
Carmel Egan, PhD, a top project management and product development executive at Eli Lilly and Co., has joined the Indiana University School of Medicine as project leader of IU's Precision Health Initiative.